163 related articles for article (PubMed ID: 11451154)
21. Pharmacological characterization of rebamipide: its cholecystokinin CCK1 receptor binding profile and effects on Ca2+ mobilization and amylase release in rat pancreatic acinar cells.
Moon SJ; An JM; Kim J; Lee SI; Ahn W; Kim KH; Seo JT
Eur J Pharmacol; 2004 Nov; 505(1-3):61-6. PubMed ID: 15556137
[TBL] [Abstract][Full Text] [Related]
22. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
23. Devazepide-induced hyperplasia in the rat liver and bile ducts.
Ohlsson B; Axelson J; Rehfeld JF; Ihse I
Eur Surg Res; 1996; 28(4):299-305. PubMed ID: 8813655
[TBL] [Abstract][Full Text] [Related]
24. Domoic acid-induced neuronal damage in the rat hippocampus: changes in apoptosis related genes (bcl-2, bax, caspase-3) and microglial response.
Ananth C; Thameem Dheen S; Gopalakrishnakone P; Kaur C
J Neurosci Res; 2001 Oct; 66(2):177-90. PubMed ID: 11592113
[TBL] [Abstract][Full Text] [Related]
25. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats.
Nakano S; Kihara Y; Otsuki M
Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141
[TBL] [Abstract][Full Text] [Related]
26. CCK inhibits the orexigenic effect of peripheral ghrelin.
Kobelt P; Tebbe JJ; Tjandra I; Stengel A; Bae HG; Andresen V; van der Voort IR; Veh RW; Werner CR; Klapp BF; Wiedenmann B; Wang L; Taché Y; Mönnikes H
Am J Physiol Regul Integr Comp Physiol; 2005 Mar; 288(3):R751-8. PubMed ID: 15550621
[TBL] [Abstract][Full Text] [Related]
27. Cholecystokinin-induced pancreatic growth involves the high-affinity CCK receptor and concomitant activation of tyrosine kinase and phospholipase D.
Rivard N; Rydzewska G; Morisset J
Ann N Y Acad Sci; 1994 Mar; 713():422-3. PubMed ID: 7514374
[No Abstract] [Full Text] [Related]
28. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor.
Funakoshi A; Miyasaka K; Shinozaki H; Masuda M; Kawanami T; Takata Y; Kono A
Biochem Biophys Res Commun; 1995 May; 210(3):787-96. PubMed ID: 7539259
[TBL] [Abstract][Full Text] [Related]
29. Portacaval shunt increases the trophic effect of cholecystokinin on the rat pancreas.
Nylander AG; Chen D; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1993 Feb; 28(2):145-8. PubMed ID: 8441908
[TBL] [Abstract][Full Text] [Related]
30. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze.
Zanoveli JM; Netto CF; Guimarães FS; Zangrossi H
Peptides; 2004 Nov; 25(11):1935-41. PubMed ID: 15501525
[TBL] [Abstract][Full Text] [Related]
31. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat.
Gronier B; Debonnel G
Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977
[TBL] [Abstract][Full Text] [Related]
32. Enterochromaffin-like cells in rat stomach respond to short-term infusion of high doses of cholecystokinin but not to long-term, sustained, moderate hyperCCKemia caused by continuous cholecystokinin infusion or pancreaticobiliary diversion.
Nylander AG; Chen D; Lilja I; Axelson J; Ihse I; Rehfeld JF; Sundler F; Håkanson R
Scand J Gastroenterol; 1993 Jan; 28(1):73-9. PubMed ID: 8430275
[TBL] [Abstract][Full Text] [Related]
33. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
34. Effect of lipopolysaccharide on expression and characterization of cholecystokinin receptors in rat pulmonary interstitial macrophages.
Xu SJ; Gao WJ; Cong B; Yao YX; Gu ZY
Acta Pharmacol Sin; 2004 Oct; 25(10):1347-53. PubMed ID: 15456538
[TBL] [Abstract][Full Text] [Related]
35. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C
Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465
[TBL] [Abstract][Full Text] [Related]
36. Chronic effect of oral cholestyramine, a bile salt sequestrant, and exogenous cholecystokinin on insulin release in rats.
Kogire M; Gomez G; Uchida T; Ishizuka J; Greeley GH; Thompson JC
Pancreas; 1992; 7(1):15-20. PubMed ID: 1557341
[TBL] [Abstract][Full Text] [Related]
37. Cholecystokinin B-type receptors mediate a G-protein-dependent depolarizing action of sulphated cholecystokinin ocatapeptide (CCK-8s) on rodent neonatal spinal ventral horn neurons.
Oz M; Yang KH; Shippenberg TS; Renaud LP; O'Donovan MJ
J Neurophysiol; 2007 Sep; 98(3):1108-14. PubMed ID: 17581850
[TBL] [Abstract][Full Text] [Related]
38. The trophic effect of cholecystokinin on the pancreas declines in rats on total parenteral nutrition.
Wu XM; Liao YW; Ji KQ; Li GF; Zang B
J Anim Physiol Anim Nutr (Berl); 2012 Apr; 96(2):214-9. PubMed ID: 21438927
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic digestive enzyme gene expression: effects of CCK and soybean trypsin inhibitor.
Rosewicz S; Lewis LD; Wang XY; Liddle RA; Logsdon CD
Am J Physiol; 1989 Apr; 256(4 Pt 1):G733-8. PubMed ID: 2468294
[TBL] [Abstract][Full Text] [Related]
40. Involvement of RhoA and its interaction with protein kinase C and Src in CCK-stimulated pancreatic acini.
Nozu F; Tsunoda Y; Ibitayo AI; Bitar KN; Owyang C
Am J Physiol; 1999 Apr; 276(4):G915-23. PubMed ID: 10198335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
